share_log

The Latest Analyst Ratings For Edwards Lifesciences

Benzinga ·  Mar 26 12:00

Ratings for Edwards Lifesciences (NYSE:EW) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings16200
Last 30D00000
1M Ago02000
2M Ago13100
3M Ago01100

Insights from analysts' 12-month price targets are revealed, presenting an average target of $91.56, a high estimate of $103.00, and a low estimate of $77.00. Observing a 10.15% increase, the current average has risen from the previous average price target of $83.12.

price target chart

Investigating Analyst Ratings: An Elaborate Study

The standing of Edwards Lifesciences among...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment